[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
The World in Medicine
December 13, 2000

Drugs in Short Supply

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;284(22):2863. doi:10.1001/jama.284.22.2863

The worldwide supply of antiparasitic drugs appears to be dwindling because markets where the drugs most commonly are used are not economically viable, according to researchers who spoke at the recent American Society of Tropical Medicine and Hygiene meeting in Houston.

"Parasites are a very common cause of disease in the world, but because there is no market for antiparasitic drugs, drug companies are discontinuing production," said A. Clayton White, Jr, MD, of Baylor College of Medicine in Houston. White's "no market" reference means that parasitic diseases occur most often in developing countries that cannot afford to support production of the drugs.

First Page Preview View Large
First page PDF preview
First page PDF preview
×